Minnesota FOIA #P009627502

Minnesota Regenerative Medicine Partnership – Development Of Novel Proteolytic Targeting Chimeras ThatPromote Cartila...

This purchase order from the Twin Cities (Minnesota) government agency awarded a contract to Mayo Clinic for $250,000 on March 26, 2022, for the development of novel proteolytic targeting chimeras that promote cartilage regeneration as part of the Minnesota Regenerative Medicine Partnership. The order involves a single lot of research services, with Mayo Clinic located in Minneapolis, MN, USA. The contract emphasizes biomedical research and regenerative medicine. No specific contract duration is indicated, but it appears to be a single-transaction award. The award was made to Mayo Clinic, a major healthcare and research provider, with no additional vendors or competitors explicitly mentioned.

Description

Minnesota Regenerative Medicine Partnership – Development Of Novel Proteolytic Targeting Chimeras ThatPromote Cartilage Regeneration